13F filing recap · Q4 2024

What did Fairfax Financial Holdings buy in Q4 2024?

Reported stock-position changes between this filing and the previous one.

Stock value

$1.56B

Positions

Estimated turnover

35.3%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

Quarter in review

Fairfax Financial Holdings opened new positions in CVS Health, Molson Coors Beverage, Cleveland-Cliffs, and Revance Therapeutics, while exiting Alphabet, Intel, Restaurant Brands International, and Tegna. The firm dramatically increased its stakes in Kraft Heinz and ATS Corp, and substantially added to Helmerich & Payne and Pfizer. It also trimmed Capri Holdings substantially and reduced Xeris Biopharma Holdings.

New positions

CVSCVS Health Corp$121.74Mreported value+2.71M shares TAPMolson Coors Beverage Co$68.01Mreported value+1.19M shares CLFCleveland-Cliffs Inc.$55.45Mreported value+5.90M shares RVNCRevance Therapeutics Inc$64.1Kreported value+21.2K shares

Increased positions

KHCKraft Heinz Co$101.77Mreported value+2.56M shares+341.9%ATSAts Corp /ats$73.87Mreported value+2.43M shares+4285.2%HPHelmerich & Payne, Inc.$24.79Mreported value+219.0K shares+39.5%BNSBank of Nova Scotia$19.27Mreported value+70.0K shares

Reduced positions

CPRICapri Holdings Ltd$1.64Mreported value-124.0K shares-61.4%XERSXeris Biopharma Holdings, Inc.$472.1Kreported value-31.3K shares-18.3%

Exited positions

GOOGLAlphabet Inc.$45.56Mprior reported value-274.6K shares-100.0%INTCIntel Corp$4.46Mprior reported value-190.0K shares-100.0%QSRRestaurant Brands International Inc.$3.02Mprior reported value-42.0K shares-100.0%TGNATegna Inc$504.6Kprior reported value-32.0K shares